BioCardia, Inc.·4

Dec 19, 8:00 AM ET

McClung David 4

4 · BioCardia, Inc. · Filed Dec 19, 2022

Insider Transaction Report

Form 4
Period: 2022-12-16
BioCardia, Inc.BCDA;BCDAW
McClung David
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-12-16$1.68/sh+8,928$14,99987,446 total
Footnotes (1)
  • [F1]These shares were purchased from the Issuer in a private placement that closed on December 16, 2022.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4